ClinicalTrials.Veeva

Menu

Novel Endoscopic Bite Block

University of Pennsylvania logo

University of Pennsylvania

Status

Enrolling

Conditions

Gastric Disease

Treatments

Device: Novel Bite Block

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This feasibility study aims to assess the safety and effectiveness of the Novel Endoscopic Bite Block. The device will be utilized in subjects undergoing routine outpatient upper endoscopy. The investigator hypothesizes that its innovative design will reduce complications associated with bite block positioning, thereby improving procedural efficiency and patient safety.

Enrollment

50 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Provision of a signed and dated Informed Consent Form (ICF).
  2. Stated willingness to comply with all study procedures and availability for the duration of the study.
  3. Male or female, ≥21 years of age.
  4. Deemed appropriate for scheduled upper endoscopy by endoscopists and anesthesia staff.

Exclusion Criteria

  1. Known allergic reactions to thermoplastic polyurethane (TPU), the component used in the manufacturing of the Flexible Endoscopic Bite Block.
  2. Any medical condition that, in the opinion of the PI, makes the subject ineligible to participate in the clinical trial.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Novel Bite Block
Experimental group
Description:
Insertion of Novel Endoscopic Bite Block in the subject's mouth following the usual manner prior to endoscopic procedure.
Treatment:
Device: Novel Bite Block

Trial contacts and locations

1

Loading...

Central trial contact

Monica Saumoy, MD, MS; Sheryl Smolensky, RN, MSN, OCN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems